US2011257730A1PendingUtilityA1
Medical devices and methods of making the same
Est. expiryOct 2, 2022(expired)· nominal 20-yr term from priority
Y10T428/31678A61F 2250/0032C23C 28/42C23C 28/345C23C 28/341C23C 28/321C23C 28/322Y10T428/31576Y10T428/12771C25D 5/48A61F 2002/91575C23C 14/16Y10T428/2995C23C 28/023A61L 31/18A61F 2002/91566A61F 2002/91533Y10T428/12C23C 28/028C23C 28/021A61B 90/39Y10T428/31544A61F 2002/91525C23C 8/10C23C 28/34C23C 14/46Y10T428/31551A61F 2250/0098Y10T428/31692C23C 28/00A61F 2/91Y10T428/31573C23C 28/36A61F 2/915C23C 28/325A61L 31/088
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An endoprosthesis, such as a stent, having a layer that can enhance the biocompatibility of the endoprosthesis, and methods of making the endoprosthesis are disclosed.
Claims
exact text as granted — not AI-modified1 . A medical implant, comprising:
a member including at least a first portion, the first portion comprising an oxide-rich surface layer and an alloy of a radiopaque material and a second material, the oxide-rich surface layer defining an outer surface of the member, the oxide-rich surface layer comprising an oxidized form of the alloy.
2 . The medical implant of claim 1 , wherein the member comprises a second portion disposed inwardly of the first portion.
3 . The medical implant of claim 2 , wherein the first portion includes a first layer consisting essentially of the radiopaque material, a second layer comprising the alloy disposed outwardly of the first layer, and the oxide-rich surface layer disposed outwardly of the second layer.
4 . The medical implant of claim 3 , wherein the first layer is more radiopaque than the second portion.
5 . The medical implant of claim 2 , wherein the second portion comprises a material selected from the group consisting of stainless steel and nickel-titanium alloy.
6 . The medical implant of claim 2 , further comprising a third portion between the first portion and the second portion.
7 . The medical implant of claim 1 , wherein the radiopaque material is selected from the group consisting of gold, platinum, palladium, and tantalum.
8 . The medical implant of claim 1 , wherein the second material is selected from the group consisting of titanium, chromium, palladium, niobium, and silicon.
9 . The medical implant of claim 1 , further comprising a polymeric layer on the member.
10 . The medical implant of claim 1 , further comprising a drug-releasing layer on the member.
11 . The medical implant of claim 1 , wherein the alloy comprises a = concentration gradient of the radiopaque material.
12 . The medical implant of claim 11 , wherein the concentration of the radiopaque material increases as a function of distance from the outer surface.
13 . The medical implant of claim 11 , wherein the concentration gradient varies substantially linearly along a thickness of the first portion.
14 . The medical implant of claim 1 , wherein the radiopaque material is capable of attenuating an incident X-ray beam by more than about 70%.
15 . The medical implant of claim 1 , wherein the radiopaque material is gold and the second material is titanium.
16 . The medical implant of claim 1 , wherein the alloy has a greater oxidation potential than the radiopaque material alone.
17 . The medical implant of claim 1 , wherein the medical implant is an orthopedic implant.
18 . The medical implant of claim 1 , wherein the medical implant is a stent or stent-graft.
19 . The medical implant of claim 1 , wherein the member is a tubular member defined by struts and openings.Join the waitlist — get patent alerts
Track US2011257730A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.